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Abstract
Background
The grades of recommendation, assessment, development and evaluation (GRADE)
approach is widely implemented in systematic reviews, health technology assessment and
guideline development organisations throughout the world. We have previously reported on
the development of the Semi-Automated Quality Assessment Tool (SAQAT), which enables
a semi-automated validity assessment based on GRADE criteria. The main advantage to
our approach is the potential to improve inter-rater agreement of GRADE assessments par-
ticularly when used by less experienced researchers, because such judgements can be
complex and challenging to apply without training. This is the first study examining the inter-
rater agreement of the SAQAT.
Methods
We conducted two studies to compare: a) the inter-rater agreement of two researchers
using the SAQAT independently on 28 meta-analyses and b) the inter-rater agreement
between a researcher using the SAQAT (who had no experience of using GRADE) and an
experienced member of the GRADE working group conducting a standard GRADE assess-
ment on 15 meta-analyses.
Results
There was substantial agreement between independent researchers using the Quality
Assessment Tool for all domains (for example, overall GRADE rating: weighted kappa 0.79;
95% CI 0.65 to 0.93). Comparison between the SAQAT and a standard GRADE assess-
ment suggested that inconsistency was parameterised too conservatively by the SAQAT.
Therefore the tool was amended. Following amendment we found fair-to-moderate
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agreement between the standard GRADE assessment and the SAQAT (for example, over-
all GRADE rating: weighted kappa 0.35; 95% CI 0.09 to 0.87).
Conclusions
Despite a need for further research, the SAQAT may aid consistent application of GRADE,
particularly by less experienced researchers.
Background
The Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) is the
most widespread method for rating the quality of evidence and grading recommendations in
healthcare [1]. More than 65 international organisations have adopted the GRADE approach,
and it is becoming an international standard. The GRADE approach for rating the quality of a
body of evidence evaluates the evidence available for a given question and outcome with
respect to several key domains. These include risk of bias, consistency of results, precision,
directness of evidence, and publication bias. Evidence from randomised controlled trials is con-
sidered high quality (valid), but can be downgraded across domains. Observational studies
begin at low quality evidence but their rating can be upgraded (provided no other limitations
have been identified in the five domains) for three primary reasons: large magnitude of effect,
evidence of a dose-response effect, confounders likely to minimize the effect. The process leads
to a rating on the quality of evidence for each outcome of high, moderate, low or very low
where high indicates that any future research is likely to be confirmatory.
A key advantage of GRADE is that it can lead to transparent judgments as a clear rationale
is needed for each downgrade of the quality of evidence [1]. Another desirable feature of the
approach is the ability to make complex nuanced judgments using a common framework that
is not based solely on review process or the type of evidence included in the synthesis.
However, there are potential drawbacks to the use of GRADE. Application of GRADE can
be complex, as implied by the lengthy series of guidance articles in the Journal of Clinical Epi-
demiology, currently standing at 15 papers [1]. This raises the possibility that multiple review-
ers may differ in their decisions and justifications to upgrade/downgrade the quality of
evidence. Although research conducted by the GRADE working group shows that two individ-
ual raters can reach substantial agreement when assessing the quality of evidence for a given
outcome [2], others have found variable agreement in assessments within and across key
domains among experienced reviewers [3].
The GRADE process may also be resource intensive. As use of GRADE is likely to increase
(grading the evidence is now a recommended step within Cochrane systematic reviews [4]),
tools which may improve the efficiency and replicability of the grading process in a resource-
constrained decision-making environment are likely to be increasingly important.
To assist with GRADE assessments and address these potential issues, we have previously
proposed a quality assessed tool based on a Bayesian network [5–6]. Bayesian networks, or
directed acyclical graphs, are graphical statistical models comprising a network of nodes con-
nected by directed links, with probability functions attached to each node to describe how
other nodes linked to it influence its contents [7]. They have applications in quality control
processes [8] and have been proposed as tools to assess internal validity in an evidence synthe-
sis context and to facilitate a complex systems approach to evidence-synthesis using a variety
of information sources and data types [8–9].
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The SAQAT provides an assessment of overall quality of evidence by formalising the struc-
ture provided by the GRADE framework in a logic model and by giving a specific weight to
each of the different items considered by GRADE. This paper has two aims. First, we assess
inter-rater reliability of the SAQAT. Second, we compare the SAQAT with a standard GRADE
assessment empirically, exploring reasons for disagreements between the two approaches, and
identifying potential areas of improvement for the semi-automated tool.
Methods
Development of the Quality Assessment Tool
SAQAT comprises two parts: a checklist and a Bayesian network. We have described the devel-
opment of these in detail in other articles [5–6]. Briefly, we developed a checklist of questions
that underpin a GRADE assessment. Responses to these questions are then used to populate
the Bayesian network. This semi-automated procedure produces probabilities of limitations
within the five domains (risk of bias, imprecision, inconsistency, indirectness, publication
bias). These are in the form of a probability distribution across potential judgements within the
domain in the GRADE framework (e.g. for risk of bias, the probability that there were no limi-
tations, serious limitations, or very serious limitations). These are then combined across
domains to provide probabilistic statements about the overall quality of evidence contained in
a systematic review (i.e. whether the quality evidence for the review was most likely high, mod-
erate, low or very low).
Risk of bias was based on items in the Cochrane risk of bias tool [4]. Inconsistency was
based primarily on visual assessment of forest plots and the statistical quantification of hetero-
geneity based on I2 and Q statistics. Indirectness included items on the applicability of the pop-
ulation, intervention, comparator, outcome, and whether conclusions were based on a direct
comparison of groups. Imprecision was based on items on the width of the confidence interval
in relation to minimally important difference and sample size. Publication bias included items
on the comprehensiveness of the search strategy, whether included studies had industry influ-
ence, funnel plot asymmetry and whether there was evidence of discrepancies between pub-
lished and unpublished trials (see Appendix 1 for a full list of items).
We have focused specifically on the context of randomised controlled trials (RCTs) where a
meta-analysis has been conducted. Therefore we did not include factors to upgrade the evi-
dence (magnitude of effect, dose-response relationship, adjusting for known confounding) as
these are recommended for use only in the context of systematic reviews of non-randomised
studies. Extension of the SAQAT for non-randomised studies is currently in progress.
Study 1: Inter-rater reliability between two independent users of the
SAQAT
Following the development and initial piloting of the checklist we conducted a more formal
evaluation of its consistency. The inter-rater agreement for each of the checklist questions is
reported in another study [6].
To evaluate the inter-rater agreement of the SAQAT, which combines the checklist with a
Bayesian network, we examined a total of 29 meta-analyses from a purposive sample of system-
atic reviews of RCTs from the Database of Systematic Reviews of Effects (DARE). Papers were
selected to ensure a diverse range of reviews from a variety of disease areas such as cardiology,
diabetes, pulmonary disease, neurological conditions and oncology. Reviews on substance mis-
use, mental health and HIV prevention were also included. Both pharmacological and non-
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pharmacological interventions were considered. We also selected reviews with varying quality
of reporting.
The checklist was used by two authors independently for all reviews. For each review a spe-
cific population, intervention, comparison and outcome (PICO) were selected beforehand to
ensure both reviewers conducted the assessment on the same PICO elements of the review.
GENIE software (freely downloadable from http://genie.sis.pitt.edu/) was used to calculate
probability distributions in the Bayesian network.
We calculated weighted kappa statistics with their associated 95% confidence interval (CI)
to compare agreement on ratings of quality of evidence. We interpreted the coefficients accord-
ing to the following guidelines: below chance—poor; 0.01–0.20 slight agreement; 0.21–0.40 fair
agreement; 0.41–0.60 moderate agreement; 0.61–0.80 substantial agreement; and 0.81–1 per-
fect agreement [10]. The following formula was used to calculate weights: 1- ((i-j) / (k-1)) ^2,
where i = rows, j = columns, and k = number of possible ratings.
Study 2: Agreement between ratings of the SAQAT and a standard
GRADE assessment
We next compared the judgements of our semi-automated tool with a standard GRADE assess-
ment conducted by an experienced user of GRADE (CW).
Formal assessment. A purposive sample of 15 recent Cochrane reviews [11–25] in mental
health was selected to reflect the area of expertise of the experienced GRADE user. A wide
range of populations, interventions, comparators, and outcomes (PICO) were deliberately cho-
sen to explore the application of the SAQAT in a variety of contexts. One set of PICO was
selected for each review. All reviews had to present meta-analyses of RCTs, since the current
tool is primarily designed for these types of reviews.
Quality of evidence was assessed for each review using the standard GRADE approach and
the SAQAT by two reviewers independently. Assessments were made for the five main
domains (risk of bias, consistency, directness, precision, publication bias), as well as overall
quality of evidence. All received a rating of high, moderate, low, or very low quality.
GRADE. One reviewer (CW) conducted assessments for each review using standard
GRADE criteria and recorded his judgements using GRADEPro software [26]. He is a long
time member of the GRADE working group, author on papers summarising GRADE methods
[27–28], and has over ten years’ experience in systematic review and guideline development.
SAQAT. One experienced systematic reviewer with no expert knowledge in mental health
(AL) and no prior experience of conducting GRADE assessments assessed the quality of evi-
dence using the standard list of questions from SAQAT. As in study 1, responses to the check-
list questions were entered into the Bayesian network using GENIE software to calculate
probability distributions for each domain and the overall quality for each review. We used
these probability distributions to derive judgements in a format reflecting standard GRADE
assessments.
Analysis. One author (NM) collated the judgements from SAQAT and the standard
GRADE assessment and identified any differences in judgements. As in study 1, we calculated
weighted kappas and 95% confidence intervals (CIs) between the standard GRADE and
SAQAT assessments for each of the five key domains (risk of bias, consistency, precision,
directness, and publication bias) and overall quality of evidence and used the same criteria and
weights for evaluating the extent of agreement.
Where the assessors always or nearly always gave the same assessment for the domain,
weighted kappas could not be calculated. Therefore we also presented the rate of agreements
for each domain and the overall quality of evidence assessment. In addition, we presented a
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table comparing ratings from GRADE and the SAQAT and summarised these discrepancies
narratively. We attempted to identify which disagreements were based on differences in raters’
judgments (e.g. what constitutes a clinically meaningful effect) from those based on properties
inherent to the SAQAT (e.g. how much weight is given to “unclear” risk of bias).
Differences between standard GRADE and SAQAT assessments were discussed among
three authors (NM, CW, AL) to understand the sources of the discrepancies.
Initial piloting of assessments and Bayesian network amendments. Before the formal
evaluation we compared our responses on one systematic review. At this initial stage we identi-
fied a different interpretation of risk of bias between the Bayesian network and the judgement
of the experienced GRADE user. Our Bayesian network, consistent with the Cochrane risk of
bias tool [4], did not downgrade for risk of bias when there was insufficient information pro-
vided by authors. However, although the risk of bias domain of GRADE is largely based on the
Cochrane tool, it was noted that the GRADE manual states that a reviewer may choose to
downgrade when insufficient information is provided in the paper assessed. We decided to
explore the impact of these differences in judgements about risk of bias in the formal stage of
assessments as it reflects the reality of subtle differences in the interpretation and application of
GRADE. It is also straightforward to parameterise the Bayesian network to reflect either
assumption. The initial version of the Bayesian network did not downgrade the risk of bias
domain due to unclear reporting. The network was then amended to reflect GRADE guidance
more closely (downgrading for unclear reporting), and the analyses were re-run to explore the
impact of this amendment on the results.
Our initial analysis also suggested the ratings of inconsistency generated by the Bayesian
network were considered too conservative and lacked face validity. Therefore, the weight of the
probabilities associated with two elements within the inconsistency domain (statistical hetero-
geneity and overlapping confidence intervals) and their interaction were amended. To reflect
the effect of this change on the results for inconsistency and overall quality of evidence,
weighted kappa scores were calculated before and after this amendment.
Results
Study 1: Comparison between SAQAT raters
Overall quality of evidence. For the overall judgement on quality of evidence there was
substantial agreement between duplicate raters using the SAQAT. There was almost perfect
agreement on risk of bias and imprecision factors; and substantial agreement for inconsistency,
indirectness, and publication bias factors. Weighted kappa results are presented in Table 1.
Risk of bias. Although there was only moderate or low agreement between raters for some
checklist items (selective reporting, no other bias, attrition bias) there was almost perfect agree-
ment for the overall rating of risk of bias.
Table 1. Comparison of raters’ judgements for two independent raters using the Semi-Automated
Quality Assessment Tool (SAQAT).
Quality rating Weighted Kappa (95% CI) Magnitude of Agreement
Overall judgement 0.79 (0.65 to 0.93) Substantial
Risk of Bias 1 Almost Perfect
Inconsistency 0.78 (0.62 to 0.95) Substantial
Indirectness 0.69 (0.44 to 0.94) Substantial
Imprecision 1 Almost Perfect
Publication bias 0.63 (0.17 to 1) Substantial
doi:10.1371/journal.pone.0123511.t001
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Imprecision. There was substantial agreement for all questions assessing imprecision and
this was reflected in the almost perfect agreement for rating imprecision.
Indirectness. Agreement between raters on the applicability of populations and interven-
tions was very low. However, there was substantial agreement on the use of surrogate outcomes
and whether conclusions were based on direct comparisons. Despite the lack of agreement on
questions of applicability there was almost perfect agreement on the overall ratings of indirect-
ness. This reflects that the use of surrogate outcomes has most weight in generating the indi-
rectness judgements.
Publication bias. There was substantial agreement for publication bias but this was lower
than for all other domains. This might partly reflect less agreement on what constitutes a suffi-
cient grey literature search and the difficulty in identifying publication biases.
Study 2: Comparison between the use of SAQAT and a standard
GRADE assessment
Quality rating judgments. Where calculable, magnitude of agreement between raters
using SAQAT and standard GRADE assessment ranged from slight to moderate across
domains before amending the Bayesian network within the SAQAT. After amending some
parameters within the inconsistency domain of the tool and changing our assumptions about
unclear reporting within the risk of bias domain, agreement across domains ranged from fair
to moderate, and agreement on overall judgment increased from slight to fair (Table 2).
After amending the tool, agreement on the risk of bias domain increased from slight to
moderate, agreement on the inconsistency domain increased from slight to fair,. Rating of
other domains remained unchanged (Table 2). The precision of the estimates was low due to
the relatively limited number of reviews that were assessed, as shown by the wide confidence
intervals.
Sources of disagreements between GRADE and SAQAT ratings. A full report of all rat-
ing decisions and brief commentaries on all disagreement between GRADE and SAQAT raters
before and after Bayesian network amendment is presented in Appendix 2. These disagree-
ments are summarised below.
Overall quality of evidence. Before amending the tool, twelve disagreements were
recorded. The ratings generated by the Bayesian network were more conservative in nine of
those, and in three cases, judgments differed by more than one level (moderate versus very
low). After amending the inconsistency domain within the Bayesian network, the number of
Table 2. Comparison of raters’ judgments for one rater using SAQAT and one rater using the standard GRADE approach (before and after SAQAT
amendment).
Quality Rating domain Weighted Kappa (95% CI) Magnitude of Agreement
Before amendment After amendment Before amendment After amendment
Risk of bias 0.13 (-0.22 to 0.48) 0.48 (0.01 to 0.94) Slight Moderate
Inconsistency 0.08 (-0.01 to 0.42) 0.30 (0 to 0.84) Slight Fair
Imprecision 0.47 (0.05 to 0.90) 0.47 (0.05 to 0.90) Moderate Moderate
Indirectness Not estimable1 Not estimable1 N/A N/A
Publication bias Not estimable2 Not estimable2 N/A N/A
Overall judgment 0.11 (-0.34 to 0.47) 0.35 (-0.09 to 0.87) Slight Fair
1 One discrepancy out of 15 judgments (93% agreement)
2 No discrepancies but only one review was rated as publication bias suspected (100% agreement)
doi:10.1371/journal.pone.0123511.t002
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disagreements was reduced to seven, and one differed by more than one level. In nearly all dis-
agreements, the overall quality of evidence ratings generated by SAQAT were more conserva-
tive than those made by the manual GRADE assessor.
In several cases, differences in severity between ratings appeared to be due to an accumulation
of probability for downgrading across domains within the Bayesian network. With the manual
GRADE assessor, quality of evidence ratings were generally based on the sum of downgrading
scores from all domains (i.e. zero, minus one or minus two based on the perceived severity of lim-
itations within each domain). Limitations that were considered too small to justify downgrading
of a domain were less likely to be taken into account in the overall assessment. On the other
hand, overall quality of evidence rating generated by the Bayesian network were affected by the
accumulation of all identified limitations within each domain, however small.
Risk of bias. Disagreements on rating of risk of bias took place in nine out of 15 assess-
ments. On three occasions, the GRADE rater downgraded the evidence due to unclear risk of
bias, whereas SAQAT did not. As discussed above, this reflected a priori differences in interpre-
tation of GRADE. The tool was amended to reflect GRADE guidance on downgrading for
unclear reporting. After this, the number of disagreements was reduced to five.
Other disagreements reflected differences in judgment between raters about whether risk of
bias was present and/or sufficiently prevalent to justify downgrading. One of the GRADE rat-
er’s decisions to downgrade was a context-specific judgment based on knowledge of treatment
area. Where disagreements occurred, the GRADE rater’s judgments were generally more con-
servative than the SAQAT rater’s. All disagreements differed by one level.
Inconsistency. Before amending the tool, disagreements about inconsistency were
recorded for eight assessments. SAQAT was always more conservative, and in five cases, judg-
ments differed by three levels (i.e. no serious inconsistency to very serious inconsistency). The
weight of the probabilities associated with statistical heterogeneity, overlapping confidence
intervals and their interaction were amended. Following this, the number of disagreements was
reduced to five, and none differed by more than one level. The most common disagreement
was based on whether variability of study estimates and effect direction were clinically mean-
ingful and therefore a sufficient reason to downgrade the quality of evidence.
Imprecision. Only three disagreements on imprecision were recorded. In two cases, the
disagreements suggested that the Bayesian network departed from the GRADE manual. The
third disagreement was based on differing interpretations of what constituted a clinically
meaningful effect. All disagreements differed by one level.
Indirectness. Only one disagreement on indirectness was recorded. The disagreement was
probably due to differences in knowledge of subject area between the raters (difference of one
level).
Publication bias. There was no disagreement between raters in this domain. This is likely
to be due to the lack of evidence of publication bias for any of the outcomes assessed.
Discussion
Summary of main findings
When comparing two independent reviewers using SAQAT we found substantial agreement
for overall quality and substantial to almost perfect agreement for all of the five domains of
GRADE (risk of bias, imprecision, inconsistency, indirectness, publication bias). Agreement
between GRADE and SAQAT on overall quality of evidence ratings was slight, and became fair
after amending assumptions about risk of bias and inconsistency within the Bayesian network.
Ratings generated by the Bayesian network were sometimes more conservative than manual
GRADE assessments.
Inter-Rater Reliability of a Semi-Automated Quality Assessment Tool
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Strengths and limitations
This is the first empirical and systematic study comparing the standard GRADE approach with
a semi-automated approach incorporating the elements of GRADE into a Bayesian network.
This study adds to the evidence that the SAQAT could be useful in the application of the
GRADE approach.
A key advantage of SAQAT is its replicability. Our study shows that SAQAT can be applied
transparently and consistently by two reviewers assessing the quality of evidence from a range of
systematic reviews of RCTs. Therefore, the Quality Assessment Tool may be a promising tool to
improve potential replicability issues observed in previous empirical comparisons between man-
ual GRADE assessors, where agreement between raters was sometimes more variable [3].
Results on the comparison between SAQAT and a standard GRADE assessment are more
mixed. Agreement between the two approaches varied across domains, although amendments
made to assumptions within the Bayesian network improved levels of agreement. The precision
of the weighted kappa estimates was low, primarily due to the relatively small sample size.
Also, it is unclear how SAQAT compares to standard GRADE assessment in other health fields.
Therefore further testing of the reliability of the tool using larger samples and in other areas is
needed to confirm our findings.
Where disagreements about overall quality of evidence occurred, ratings generated by
SAQAT tended to be more conservative. This may be because, unlike manual GRADE assess-
ment, the Bayesian network automatically takes into account the accumulation of multiple lim-
itations in the evidence, however small. Therefore this may reflect the strength of SAQAT
approach when evaluating systematic review evidence where there are multiple small probabili-
ties of limitations in the evidence.
For the analyses, only the highest probability provided by the Bayesian network was taken
into account. Evidence profiles can also be presented as probability distributions representing
the uncertainty underlying these judgements. These figures may be presented alongside or as
an alternative to standard evidence profiles produced by GRADE Pro (see Fig 1 and Fig 2).
Suggestions for further research
The current version of SAQAT is applicable to systematic reviews that include meta-analyses
of RCTs. The GRADE approach can also be applied to meta-analyses of observational studies
Fig 1. Example evidence profile using GRADEpro.
doi:10.1371/journal.pone.0123511.g001
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and narrative approaches to synthesising evidence. Further work is currently in progress to
adapt and validate our approach for such reviews.
Despite numerous publications about the GRADE approach and widespread use, there
remain few empirical and systematic evaluations of its application. Further research on how
SAQAT compares to standard GRADE assessments in other medical fields and with bigger
samples is required to confirm the findings of this study.
Some aspects of the GRADE framework are better supported by evidence than others. Fur-
ther changes to the structure and parameterisation of SAQAT would allow qualitative and
quantitative exploration of the potential weight and impact of (and interaction between) spe-
cific elements within domains, including those elements that are less certain. Methodological
applications could involve mapping probabilities of bias and applying them, or formally elicit-
ing expert opinion to generate distributions for the probabilities reflecting uncertainty
appropriately.
Suggestions for further practice
Use of SAQAT is probably most likely to benefit those with limited experience of using
GRADE. However, given the complexity of GRADE, we think that experienced users of this
approach may also benefit from a reminder of key criteria to help ensure consistent and repeat-
able quality of evidence ratings. We also think that institutions considering adopting GRADE,
but concerned about the resource and training implications, may also benefit.
A further benefit of using SAQAT is the potential in the future to automate the entire pro-
cess of validity assessment. For example, nodes can be parameterised using text mining soft-
ware or data stored by document management systems used for review production and storage
(such as ARCHIE used by the Cochrane Collaboration). The benefits of automation are gaining
more attention as a response to the challenges of conducting increasingly large and complex
evidence syntheses in a timely manner to inform decision makers.
Fig 2. Example evidence profile with probability distributions from Bayesian network.
doi:10.1371/journal.pone.0123511.g002
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Conclusions
The Semi-Automated Quality Assessment Tool (SAQAT), a checklist of questions and a Bayes-
ian network designed to model judgements according to GRADE criteria, can produce consis-
tent and reproducible judgements about the quality of evidence from meta-analyses of RCTs.
Despite a need for further research, SAQAT may aid consistent application of GRADE, partic-
ularly by less experienced reviewers.
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